Stephen Ross
NYU Langone Health · NYU Langone Medical Center · New York University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Stephen Ross as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:26 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07909408 · Psilocybin FCR Early-Stage Breast CancerNYU Langone Health · not yet recruiting · Early-stage Breast Cancer, Fear of Cancer Recurrence, Anxiety · principal investigator
- Ph2/Ph3NCT05398484 · Psilocybin Therapy in Advanced CancerNYU Langone Health · recruiting · Advanced Cancer · principal investigator
- Ph3NCT05033028 · Smartphones for Opiate Addiction RecoveryNYU Langone Health · recruiting · Opioid-use Disorder · principal investigator
- Ph1/Ph2NCT04760613 · CBD for Chronic Radicular Pain on Chronic Opioid Therapy (COT)NYU Langone Health · completed · Radiculopathy · principal investigator
- Ph1NCT02421263 · The Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Religious ProfessionalsNYU Langone Health · completed · Religious or Spiritual Problem · principal investigator
- Ph2NCT02106325 · Ketamine as a Rapidly-Acting Antidepressant in Depressed Emergency Department PatientsNYU Langone Health · completed · Depression · principal investigator
- Ph1NCT01527994 · Aprepitant Effects in Intravenous Heroin DependenceNYU Langone Health · completed · Opioid Dependence · principal investigator
- Early Ph1NCT00957359 · Psilocybin Cancer Anxiety StudyNYU Langone Health · completed · Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:26 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 8 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Psilocybin Therapy for Advanced Cancer-related Psychiatric DistressR01CA268521 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · fiscal years 2022 to 2026 · $668,332 awarded in 2026Same name and institution; not confirmed by an ID
- Psilocybin-assisted Psychotherapy to Treat Fear of Cancer Recurrence in Early- Stage Breast CancerR01CA312541 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · fiscal years 2026 · $693,638 awarded in 2026Grant number is on one of their registry trials
- Effects of cannabidiol in chronic non-cancer pain on chronic opioid therapyR21DA048986 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · fiscal years 2019 to 2020 · $211,875 awarded in 2020Same name and institution; not confirmed by an ID
- Clinical Laboratory Evaluations of Aprepitant for the Treatment of Opioid DependeR01DA027151 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · fiscal years 2010 to 2013 · $180,384 awarded in 2013Grant number is on one of their registry trials
Most cited trial papers
Clinical-trial papers with this author name in breast cancer, ranked by citations from NIH iCite, fetched 2026-11-12 10:26 UTC. The ranking covers the 200 most relevant of 2 PubMed records, and a shared surname and initials can bring in a namesake. All 2 on PubMed
- Couples' support-related communication, psychological distress, and relationship satisfaction among women with early stage breast cancer.J Consult Clin Psychol · 2004139 citationsRCR 5.2
- Couple-focused group intervention for women with early stage breast cancer.J Consult Clin Psychol · 200594 citationsRCR 3.5